Acamprosate, Criteria for Non-Formulary Use |
Agalsidase, Criteria for Non-Formulary Use |
Alemtuzumab, Criteria For Non-Formulary Use |
Aliskiren, Criteria For Non-Formulary Use |
Alpha-Adrenergic Blockers in the Management of Patients with HTN (ALLHAT) |
Antiviral Agents for Influenza, Criteria For Use |
Azacitidine, Criteria for Use |
Topical Anesthesia for Surfaces of the Nasopharynx, Oropharynx, Laryngotracheal Region and Airway, Criteria for Use |
Cholinesterase Inhibitors, Criteria for Use |
Clinically Uroselective Alpha Adrenergic Blockers, Criteria for Non-Formulary Use |
Combination Alpha-Blocker & Finasteride Therapy for BPH, Criteria for Use |
Consensus Interferon, Criteria for use in Hepatitis C, Criteria for Use |
Angiotensin II Receptor Antagonists (AIIRAs), Criteria for Use |
Antiemetic, Criteria for Use |
Atazanavir, Criteria for Use |
Becaplermin, Criteria for Non-Formulary Use |
Beta-Adrenergic Blockers (Heart Failure), Clinical Recommendations |
Biologics for Psoriasis, Criteria for Non-Formulary Use (Updated) |
Buprenorphine, Criteria for Use |
Cilostazol, Criteria for Use |
Cinacalcet, Criteria for Non-Formulary Use |
Clopidogrel, Criteria for Use |
Darunavir, Criteria for Use |
Dihydropyridine (Long-Acting) Calcium Channel Blockers, Clinical Guidance |
Drotrecogin Alfa, Criteria for Use |
Drotrecogin Alfa Checklist |
Duloxetine, Criteria for Non-Formulary Use |
Enfuvirtide,, Criteria for Use |
Endothelin Receptor Antagonists (ERA), Criteria for Use |
Enoxaparin, Criteria for Use in Mechanical Heart Valve Patients |
Erlotinib, Criteria for Non-Formulary Use |
Erythropoietin Criteria for Use for Hepatitis C,, Criteria for Use |
Eszopiclone, Criteria for Non-Formulary Use |
Etravirine, Criteria for Use |
Exenatide, Criteria for Non-Formulary Use |
Ezetimibe or Ezetimibe+Simvastatin Criteria for Non-Formulary Use |
Fentanyl Transdermal Patch, Criteria for Use |
Fondaparinux, Criteria for Use |
Fluoroquinolone, Criteria for Use |
Fuzeon Criteria for Use |
Gabapentin, Criteria for Use |
Gefitinib Criteria for Non-Formulary Use |
GSCF Criteria for Use for Hepatitis C Criteria for Use |
Highly Teratogenic Retinoids and High-dose Vitamin A, Criteria for
Use |
Hyaluronic Acid-Hylan G-F 20, Criteria for Use |
Imatinib, Criteria for use |
Initiating Therapy In Early Parkinson’s Disease, Criteria for use |
Imiquimod, Criteria for Use |
Leflunomide and Biologic DMARDs for Rheumatoid Arthritis, Criteria for use |
Leukotriene Inhibitor, Criteria for Use |
Leuprolide Implantable (Viadur) Criteria for Non-Formulary Use |
Levetiracetam, Criteria for Use |
Linezolid, Quinupristin-Dalfopristin, and Daptomycin,, Criteria for Use |
Lovaza (formerly Omacor),, Criteria for Use |
Lubiprostone Criteria for Non-Formulary Use |
Maraviroc, Criteria for Use (Check-Box Format) |
Memantine, Criteria for Use |
Meperidine, Criteria for Use |
Monoamine Oxidase Inhibitors (MAOI), Criteria for Use |
Montelukast, Criteria for Use |
Moxifloxacin Ophthalmic Solution, Criteria for Use |
Naltrexone Extended-release Injectable Suspension Criteria for Non-formulary Use |
Factor VII, Recombinant Activated (Novoseven®) , Criteria for Non-Formulary Use |
Omalizumab, Criteria for Non-formulary Use |
Orlistat - Criteria for Use |
Oxycodone CR, Criteria for use, Treatment Algorithm |
Oxymorphone Oral Tablets - Criteria for Use |
Pantoprazole I.V. Criteria for Use Pantoprazole I.V. Literature Review |
Pegaptanib, Criteria for Non-Formulary Use |
Pegfilgrastim, Criteria for Non-Formulary Use |
Pemetrexed, Criteria for Non-Formulary Use |
Pharmacologic Management of Primary Pulmonary Hypertension, Criteria for Use |
Phosphate binder (Lanthanum, Sevelamer), Criteria for Use |
Pramlintide, Criteria for Non-Formulary Use |
Pregabalin, Criteria for Non-Formulary Use |
Propoxyphene, Criteria for Use |
Proton Pump Inhibitors, High-dose, Criteria for Use |
Appendix I(Nocturnal Leg Cramps) |
Quadrivalent HPV Vaccine (Gardasil), Criteria for Non-Formulary Use |
Raltegravir, Criteria for Use |
Ramipril, Criteria for Non-Formulary Use |
Ranolazine, Criteria for Non-Formulary Use |
Rifaximin, Criteria for Non-Formulary Use |
Rifaximin, Criteria for Non-Formulary Use (Check-box format) |
Risperidone Long-Acting, Criteria for Use |
Rituximab, Criteria for Use |
Sibutramine - Criteria for Use |
Sitagliptin, Criteria for Non-Formulary Use |
Statins, Criteria for Non-Formulary Use in Patients Receiving Protease Inhibitor Therapy |
Statin (fluvastatin, pravastatin, atorvastatin and rosuvastatin), Criteria for Use |
Teriparatide, Criteria for Non-Formulary Use |
Thickening Agents for Outpatients, Criteria for Use |
Tiotropium, Criteria for Use |
Tipranavir, Criteria for Use |
Thiazolidinedione , Criteria for Non-Formulary Use |
Vardenafil Non-Responders, Criteria for Non-Formulary Use |
Varenicline Criteria for Prescribing |
Ziconotide, Criteria for Non-Formulary Use & Ziconotide, Monograph |
Ziprasidone IM, Criteria for Non-Formulary Use |
Ziprasidone, Criteria for Use |
Zoledronic Acid (Reclast), Criteria for Use |
Zoster Vaccine, Criteria for Use |